
Sign up to save your podcasts
Or
In healthcare, the holy graille seems to be longevity. We look at whether a treatment increases lifespan and use that as a barometer for it's value.
But should that be the yardstick we use? Or would we be better off with a more subjective measure of improving quality of life, even if that means sacrificing some of the quantity.
Today, 2 Docs Talk about this question propose some things to consider as you consider your approach to aging and healthcare.
Resources:
Colonoscopy study in the Annals of Internal Medicine
Research on lifespan in Nature
The Austad/Olshansky Wager
In healthcare, the holy graille seems to be longevity. We look at whether a treatment increases lifespan and use that as a barometer for it's value.
But should that be the yardstick we use? Or would we be better off with a more subjective measure of improving quality of life, even if that means sacrificing some of the quantity.
Today, 2 Docs Talk about this question propose some things to consider as you consider your approach to aging and healthcare.
Resources:
Colonoscopy study in the Annals of Internal Medicine
Research on lifespan in Nature
The Austad/Olshansky Wager